PI
GILD icon

PFG Investments’s Gilead Sciences GILD Stock Holding History

PFG Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
18,640
+643
+4% +$84.7K 0.09% 188
2026
Q1 		$2.51M Buy
17,997
+5,715
+47% +$800K 0.12% 157
2025
Q4 		$1.51M Buy
12,282
+1,306
+12% +$159K 0.07% 245
2025
Q3 		$1.22M Buy
10,976
+120
+1% +$13.6K 0.06% 280
2025
Q2 		$1.2M Sell
10,856
-1,143
-10% -$122K 0.07% 252
2025
Q1 		$1.34M Sell
11,999
-25,026
-68% -$2.58M 0.09% 222
2024
Q4 		$3.42M Sell
37,025
-48
-0.1% -$4.32K 0.21% 85
2024
Q3 		$3.11M Sell
37,073
-1,399
-4% -$107K 0.2% 89
2024
Q2 		$2.64M Buy
38,472
+1,484
+4% +$99K 0.19% 98
2024
Q1 		$2.71M Buy
36,988
+27,709
+299% +$2.13M 0.16% 129
2023
Q4 		$752K Sell
9,279
-6,839
-42% -$532K 0.14% 166
2023
Q3 		$1.21M Sell
16,118
-804
-5% -$61.8K 0.23% 90
2023
Q2 		$1.3M Sell
16,922
-982
-5% -$78.3K 0.23% 93
2023
Q1 		$1.49M Buy
+17,904
New +$1.48M 0.3% 70

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFG Investments's GILD Position: Q2 2026 in Review

PFG Investments increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $84.7K and bringing the position to 18,640 shares worth $2.35M. The position accounts for 0.09% of the portfolio, ranked #188.

PFG Investments first reported a position in GILD in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.42M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PFG Investments held 18,640 shares of Gilead Sciences worth $2.35M as of Q2 2026.
  • PFG Investments bought 643 Gilead Sciences shares in Q2 2026, an estimated $84.7K.
  • Gilead Sciences made up 0.09% of PFG Investments's portfolio in Q2 2026, its #188 holding.
  • PFG Investments first reported a position in Gilead Sciences in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's Gilead Sciences position peaked at $3.42M in Q4 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.